Table 1

Examples of multicentre dementia studies including an advanced imaging component

Study nameAcronymNo recruitedParticipant characteristicsNo of sites
Alzheimer’s Disease Neuroimaging Initiative56 ADNI800 (ADNI1)+
200 (ADNI GO)+
650 (ADNI2)
AD/MCI, controls57 (USA+Canada)
Parkinson’s Progression Markers Initiative59 PPMI400Parkinson’s disease30 (12 countries)
200Controls
Longitudinal Frontotemporal Lobar Degeneration6 w271 ARTFL-LEFFTDS1560FTD14 (USA+Canada)
Genetic Frontotemporal dementia Initiative5 GENFI1100Familial FTD27 (11 countries)
Dominantly Inherited Alzheimer Network Trial7 w72 DIAN-TU490Familial AD42 (17 countries)
Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageingw272 AIBL1000Ageing individuals, AD/MCI6 (Australia)
DZNE Longitudinal Cognitive Impairment and Dementia Study study60 DELCODE1000Predementia8 (Germany)
Longitudinal Early-Onset Alzheimer’s Disease Studyw273 LEADS600AD aged between 40 and 6414 (USA)
4 Repeat Tauopathy Neuroimaging Initiativew274 4RTNI110PSP or CBD2 (USA)
Progressive Supranuclear Palsy Corticobasal Syndrome Multiple System Atrophy Longitudinal Studyw275 PROSPECT900PSP, CBS, atypical Parkinsonism7 (UK)